About Braveheart Bio
Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart’s goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity. With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart...
Leadership at Braveheart Bio
The team at the top of the org chart.
Travis Murdoch
CEO and President
Open Jobs at Braveheart Bio (6)
- Braveheart Bio · San Francisco, CA or Remote or… · 3d$170k – $195k
- Braveheart Bio · San Francisco, CA or Remote or… · 4d$175k – $210k
- Braveheart Bio · San Francisco, CA or Remote or… · 4d$225k – $290k
- Braveheart Bio · San Francisco, CA or Remote or… · 22d$125k – $145k
- Braveheart Bio · San Francisco, CA or Remote or… · 29d$230k – $325k
- Braveheart Bio · San Francisco, CA or Remote or… · 1mo$140k – $170k